R-CEOP Regimen

Preferred Label : R-CEOP Regimen;

NCIt synonyms : Cyclophosphamide/Etoposide/Oncovin/Prednisone Plus Rituxan Regimen; CEOP/Rituximab Regimen; CEOP Plus Rituximab Regimen; Cyclophosphamide/Etoposide/Prednisone/Rituximab/Vincristine; Cyclophosphamide-Etoposide-Prednisone-Rituximab-Vincristine; Cyclophosphamide/Etoposide/Prednisone/Rituximab/Vincristine Regimen; Cyclophosphamide-Etoposide-Prednisone-Rituximab-Vincristine Regimen;

NCIt related terms : R-CEOP (Etoposide);

NCIt definition : A regimen consisting of cyclophosphamide, etoposide, vincristine, prednisone and rituximab that may be used in the treatment of diffuse large B-cell lymphoma (DLBCL) and post-transplant lymphoproliferative disorders.;

NCI Metathesaurus CUI : CL1905180;

Codes from synonyms : 16155;

Details

Origin ID

C191761;

UMLS CUI

C5784714;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Cyclophosphamide [NCIt concept]
- Etoposide [NCIt concept]
- Prednisone [NCIt concept]
- Rituximab [NCIt concept]
- Vincristine Sulfate [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients